Cargando…
Serum irisin levels and osteoporosis in patients with advanced chronic kidney disease and renal transplant recipients
AIM: To elucidate the association of serum irisin levels with bone mineral density (BMD) and calcium–phosphorus metabolism parameters in chronic kidney disease (CKD) patients and renal transplant recipients (RTRs). METHODS: This is a cross-sectional study involving CKD patients and RTRs. Healthy vol...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293367/ https://www.ncbi.nlm.nih.gov/pubmed/36773217 http://dx.doi.org/10.1007/s11255-023-03475-7 |
_version_ | 1785062985901801472 |
---|---|
author | Demir, Canan Dursun, Ali Doğan Sarıyıldız, Gülçin Türkmen Arslan, Aykut İlker |
author_facet | Demir, Canan Dursun, Ali Doğan Sarıyıldız, Gülçin Türkmen Arslan, Aykut İlker |
author_sort | Demir, Canan |
collection | PubMed |
description | AIM: To elucidate the association of serum irisin levels with bone mineral density (BMD) and calcium–phosphorus metabolism parameters in chronic kidney disease (CKD) patients and renal transplant recipients (RTRs). METHODS: This is a cross-sectional study involving CKD patients and RTRs. Healthy volunteers served as controls. Age, gender, and dialysis vintage were recorded. Serum irisin, creatinine, glucose, calcium, albumin, 25(OH) vitamin D, ferritin, C-reactive protein, A1C, and lipid profile were studied in all participants. Estimated glomerular filtration rate (eGFR), corrected calcium, and body mass index (BMI) were calculated. RESULTS: Overall, 49 patients (23 hemodialysis, 26 RTRs) and 25 control subjects were included. In hemodialysis (HD) group, 8 patients (34.8%) had osteoporosis, and 12 patients (52.2%) had osteopenia. In RTR group, 3 patients (11.5%) had osteoporosis, while 15 patients (57.7%) had osteopenia. Among controls, one had osteoporosis, and 7 had osteopenia. There was no significant difference between HD and RTRs; however, osteoporosis rate was significantly lower in control subjects. BMD measurements (femur and lumbar T- and Z-scores) were comparable between HD and RTR groups. Control group DEXA values were similar to RTRs; however, they were significantly higher compared to HD group. 25(OH) vitamin D levels were comparable between the HD and RTR groups, and these were significantly lower compared to values of the control group. Mean serum irisin level was 426.6 ± 191.2 pg/mL in hemodialysis group, 342.6 ± 174.8 in the RTR group, and 208.0 ± 186.1 in controls. Serum irisin levels were similar in RTR and HD groups, but their values were significantly higher compared to controls. When we compared serum irisin levels between patients with and without osteoporosis in the whole cohort and hemodialysis and RTR groups, there was no difference. Serum irisin was positively correlated with lumbar T-score both in hemodialysis and RTR groups. CONCLUSION: Our study is the first in the literature revealing the positive correlation of serum irisin level with femur T-score in RTRs. Serum irisin level was also positively correlated with femur T-scores in hemodialysis patients. |
format | Online Article Text |
id | pubmed-10293367 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-102933672023-06-28 Serum irisin levels and osteoporosis in patients with advanced chronic kidney disease and renal transplant recipients Demir, Canan Dursun, Ali Doğan Sarıyıldız, Gülçin Türkmen Arslan, Aykut İlker Int Urol Nephrol Nephrology - Original Paper AIM: To elucidate the association of serum irisin levels with bone mineral density (BMD) and calcium–phosphorus metabolism parameters in chronic kidney disease (CKD) patients and renal transplant recipients (RTRs). METHODS: This is a cross-sectional study involving CKD patients and RTRs. Healthy volunteers served as controls. Age, gender, and dialysis vintage were recorded. Serum irisin, creatinine, glucose, calcium, albumin, 25(OH) vitamin D, ferritin, C-reactive protein, A1C, and lipid profile were studied in all participants. Estimated glomerular filtration rate (eGFR), corrected calcium, and body mass index (BMI) were calculated. RESULTS: Overall, 49 patients (23 hemodialysis, 26 RTRs) and 25 control subjects were included. In hemodialysis (HD) group, 8 patients (34.8%) had osteoporosis, and 12 patients (52.2%) had osteopenia. In RTR group, 3 patients (11.5%) had osteoporosis, while 15 patients (57.7%) had osteopenia. Among controls, one had osteoporosis, and 7 had osteopenia. There was no significant difference between HD and RTRs; however, osteoporosis rate was significantly lower in control subjects. BMD measurements (femur and lumbar T- and Z-scores) were comparable between HD and RTR groups. Control group DEXA values were similar to RTRs; however, they were significantly higher compared to HD group. 25(OH) vitamin D levels were comparable between the HD and RTR groups, and these were significantly lower compared to values of the control group. Mean serum irisin level was 426.6 ± 191.2 pg/mL in hemodialysis group, 342.6 ± 174.8 in the RTR group, and 208.0 ± 186.1 in controls. Serum irisin levels were similar in RTR and HD groups, but their values were significantly higher compared to controls. When we compared serum irisin levels between patients with and without osteoporosis in the whole cohort and hemodialysis and RTR groups, there was no difference. Serum irisin was positively correlated with lumbar T-score both in hemodialysis and RTR groups. CONCLUSION: Our study is the first in the literature revealing the positive correlation of serum irisin level with femur T-score in RTRs. Serum irisin level was also positively correlated with femur T-scores in hemodialysis patients. Springer Netherlands 2023-02-11 2023 /pmc/articles/PMC10293367/ /pubmed/36773217 http://dx.doi.org/10.1007/s11255-023-03475-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Nephrology - Original Paper Demir, Canan Dursun, Ali Doğan Sarıyıldız, Gülçin Türkmen Arslan, Aykut İlker Serum irisin levels and osteoporosis in patients with advanced chronic kidney disease and renal transplant recipients |
title | Serum irisin levels and osteoporosis in patients with advanced chronic kidney disease and renal transplant recipients |
title_full | Serum irisin levels and osteoporosis in patients with advanced chronic kidney disease and renal transplant recipients |
title_fullStr | Serum irisin levels and osteoporosis in patients with advanced chronic kidney disease and renal transplant recipients |
title_full_unstemmed | Serum irisin levels and osteoporosis in patients with advanced chronic kidney disease and renal transplant recipients |
title_short | Serum irisin levels and osteoporosis in patients with advanced chronic kidney disease and renal transplant recipients |
title_sort | serum irisin levels and osteoporosis in patients with advanced chronic kidney disease and renal transplant recipients |
topic | Nephrology - Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293367/ https://www.ncbi.nlm.nih.gov/pubmed/36773217 http://dx.doi.org/10.1007/s11255-023-03475-7 |
work_keys_str_mv | AT demircanan serumirisinlevelsandosteoporosisinpatientswithadvancedchronickidneydiseaseandrenaltransplantrecipients AT dursunalidogan serumirisinlevelsandosteoporosisinpatientswithadvancedchronickidneydiseaseandrenaltransplantrecipients AT sarıyıldızgulcinturkmen serumirisinlevelsandosteoporosisinpatientswithadvancedchronickidneydiseaseandrenaltransplantrecipients AT arslanaykutilker serumirisinlevelsandosteoporosisinpatientswithadvancedchronickidneydiseaseandrenaltransplantrecipients |